Facente Consulting helped shape and execute an epidemiological analysis of patterns related to recency of HIV infection at the time of diagnosis in San Francisco, in relation to the COVID-19 pandemic.
Facente Consulting analyzed qualitative data from interviews with 92 cranio-maxillofacial surgeons worldwide to identify key training needs.
Dr. Facente was a co-investigator on this two-year research study funded by the National Institute on Drug Abuse (NIDA), with the goal of better understanding the epidemiology of hepatitis C in three high-burden subpopulations in San Francisco.
Facente Consulting was hired during the formation of End Hep C SF to provide “backbone support” for this collective impact initiative, assist with strategic planning, and lead research and surveillance activities to monitor progress toward hepatitis C elimination.
Dr. Tan at UCSF reached out to Facente Consulting for ongoing assistance with manuscript development, literature reviews, and technical editing to support grant submissions, helping to move her academic portfolio forward and support her overall research goals.
Facente Consulting assisted a medical team at Stanford’s academic hospital with analyzing both qualitative and quantative survey data collected to explore the experiences and effects of gendered microaggressions by patients toward physicians.
Facente Consulting was hired by academic physicians at Stanford’s School of Medicine to coordinate the qualitative research aspects of a study designed to better understand gender-based differences in how academic physicians think about and experience success in their careers.
Dr. Facente served as the project manager for the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) for more than a decade, providing high-level project coordination and analytic support to researchers focused on HIV incidence estimation around the world.
The World Health Organization hired Facente Consulting to lead a team of subject matter experts to (i) systematically review the use of HIV recency assays for public health surveillance and (ii) write an updated technical guidance document on assay use for use by countries around the world.
Facente Consulting is implementing an evaluation of Harm Reduction Michigan’s initiative to establish naloxone boxes as a form of overdose prevention.
In 2021, Facente Consulting was hired to take notes of a national meeting of U.S. experts exploring the potential of fluvoxamine as an early treatment for COVID-19, and turn the meeting outcomes into a peer-reviewed publication in a high-profile clinical journal.
Facente Consulting served as the lead evaluator for a local LGBTQ+ mental health-focused impact evaluation that involved evaluation design, managing IRB approvals, overseeing data collection, and quantitative analysis.
